Related Experiment Video
Updated: Apr 4, 2026

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells
Published on: January 16, 2026
MicroRNA-126 Overexpression Inhibits Proliferation and Invasion in Osteosarcoma Cells
Shuaihua Wang1, Xinlei Wang2, Qiang Guo3
1Department of Pediatric Orthopedics and Bone Oncology, Linyi People's Hospital Affiliated to Shandong University, Linyi, Lanshan, Shandong, P.R. China.
Abstract:
This study investigated the biological effects of microRNA-126 overexpression in human MG63 osteosarcoma cells. A recombinant plasmid expressing microRNA-126, pcDNA6.2-microRNA-126, was constructed and transfected into MG63 cells. Using real-time fluorogenic quantitative polymerase chain reaction, the microRNA-126 expression was measured in microRNA-126-MG63 group, Ctrl-MG63 group, and blank group. Cell proliferation, cell cycle distribution, cell migration, and invasion were analyzed using methyl thiazolyl tetrazolium assay, flow cytometer, wound-healing assay, and transwell assay, respectively. As expected, microRNA-126 expression was higher in microRNA-126-MG63 group than in Ctrl-MG63 group and blank group (both P < .05). After 48/72 hours of transfection, cell proliferation in microRNA-126-MG63 group was significantly reduced compared to blank group (both P < .05). Compared to blank group, cell population in G0/G1 stage was significantly higher in microRNA-126-MG63 group, accompanied by lower cell numbers in the S and G2/M phases and decreased proliferation index (all P < .05). Wound-healing assay showed a wider scratch width in microRNA-126-MG63 group and reduced cell migration than blank group (both P < .05). Cells overexpressing microRNA-126 exhibited reduced ADAM9 expression levels compared to other 2 groups (all P < .05), suggesting ADAM9 is a target of microRNA-126. Cell proliferation, migration, and invasion rates were reduced in microRNA-126 group after 48/72 hours of transfection, compared with blank group (all P < .05). Cotransfection of pcDNA6.2-microRNA-126 and pMIR-ADAM9 into MG63 cells led to higher cell proliferation, invasion, and migration rates, compared with transfection of pcDNA6.2-microRNA-126 alone (all P < .05). In summary, our data show that microRNA-126 inhibits cell proliferation, migration, and invasion in human osteosarcoma cells by targeting ADAM9.
Insights
MicroRNA-126 overexpression inhibits proliferation, migration, and invasion in human osteosarcoma cells. This effect is mediated by targeting ADAM9, a key regulator of these cellular processes.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Osteosarcoma is a primary malignant bone tumor with a high risk of metastasis.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and play crucial roles in various biological processes, including cancer development.
- Dysregulation of miRNA expression is implicated in the pathogenesis of many cancers, including osteosarcoma.
Purpose of the Study:
- To investigate the biological effects of microRNA-126 (miR-126) overexpression in human MG63 osteosarcoma cells.
- To determine the impact of miR-126 on cell proliferation, cell cycle, migration, and invasion.
- To elucidate the underlying molecular mechanism, specifically the role of ADAM9 as a potential target of miR-126.
Main Methods:
- Construction and transfection of a recombinant plasmid (pcDNA6.2-microRNA-126) into MG63 cells.
- Quantification of miR-126 expression using real-time quantitative polymerase chain reaction.
- Assessment of cell proliferation (MTT assay), cell cycle distribution (flow cytometry), cell migration (wound-healing assay), and invasion (Transwell assay).
- Analysis of ADAM9 expression levels.
Main Results:
- miR-126 expression was significantly upregulated in transfected MG63 cells.
- Overexpression of miR-126 led to a significant reduction in cell proliferation, migration, and invasion.
- miR-126 induced G0/G1 cell cycle arrest and decreased the proliferation index.
- ADAM9 expression was significantly reduced in cells overexpressing miR-126, indicating ADAM9 is a direct target.
- Restoring ADAM9 expression partially reversed the inhibitory effects of miR-126 on cell proliferation, migration, and invasion.
Conclusions:
- MicroRNA-126 acts as a tumor suppressor in human osteosarcoma cells.
- miR-126 inhibits cell proliferation, migration, and invasion by targeting ADAM9.
- These findings highlight the potential of miR-126 as a therapeutic target for osteosarcoma.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

